miR-363 confers taxane resistance in ovarian cancer by targeting the Hippo pathway member, LATS2

Mohamed, Z., Hassan, M.K., Okasha, S. et al. (7 more authors) (2018) miR-363 confers taxane resistance in ovarian cancer by targeting the Hippo pathway member, LATS2. Oncotarget, 9 (53). pp. 30053-30065. ISSN 1949-2553

Abstract

Metadata

Item Type: Article
Authors/Creators:
Copyright, Publisher and Additional Information:

© 2018 Mohamed et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Keywords: LATS2; chemoresistance; miR-363; ovarian cancer; taxane
Dates:
  • Accepted: 4 June 2018
  • Published (online): 10 July 2018
  • Published: 10 July 2018
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Science (Sheffield) > School of Biosciences (Sheffield) > Department of Molecular Biology and Biotechnology (Sheffield)
Depositing User: Symplectic Sheffield
Date Deposited: 15 Oct 2018 14:25
Last Modified: 22 Apr 2024 15:39
Status: Published
Publisher: Impact Journals
Refereed: Yes
Identification Number: 10.18632/oncotarget.25698
Related URLs:
Open Archives Initiative ID (OAI ID):

Export

Statistics